Mark Tann

Medicine · Indiana University

Prostate Cancer Treatment and Research Hepatocellular Carcinoma Treatment and Prognosis Prostate Cancer Diagnosis and Treatment Medical Imaging Techniques and Applications Radiopharmaceutical Chemistry and Applications

Publications

119

Citations

2,668

Est. group size

—

Recurring co-author estimate

Active years

Publishing since 1997

Research summary

AI-generated

Mark Tann conducts research in nuclear medicine and medical imaging, focusing on advanced scanning techniques (such as PET/CT and SPECT/CT) to diagnose, stage, and monitor treatment response in various cancers. Much of the work involves radioactive tracers that highlight specific tissues or tumors, including studies on liver, neuroendocrine, prostate, thyroid, and parathyroid conditions. The research often aims to improve the accuracy of imaging and its usefulness in guiding cancer therapy.

Nuclear medicine imaging (PET/CT and SPECT/CT)Radioactive tracers and radiopharmaceuticals for cancerFunctional liver imaging to guide radiation therapyNeuroendocrine tumor imaging and treatment responseCancer diagnosis and treatment monitoring

Publication activity has been steady with fluctuations over the past decade, with a notable peak in 2019 and renewed higher output in 2024 and 2025.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence

Publications per year over the last 10 years — averaging 7.2/year recently

Recent publications

Evaluating the Role of Pretherapy Scans in Post-Thyroidectomy Thyroid Cancer Management: Predictive Value, Management Impact, and Efficacy
Proceedings of IMPRS · 2025
Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
HepatoBiliary Surgery and Nutrition · 2022
Which reference tissue is best for semiquantitative determination of 68Ga-PSMA-11 activity in PET/CT?
Journal of Nuclear Medicine · 2020
Quantitative123I-MIBG SPECT/CT to assess treatment response in patients with neuroblastoma - feasibility and correlation to visual evaluation.
Journal of Nuclear Medicine · 2020
Prospective trial of functional liver image-guided hepatic therapy (FLIGHT) with hepatobiliary iminodiacetic acid (HIDA) scans and update of institutional experience.
Journal of Clinical Oncology · 2019
Dynamic SPECT/CT HIDA imaging, an improved technique for quantitative Liver function ?
2019
Can we use Functional Liver imaging for evaluation of post radiation toxicity from Y90 and SBRT therapies
Journal of Nuclear Medicine · 2019
Pilot Study to Evaluate Prognostic and Predictive Markers of Peptide Receptor Radionucleotide Therapy Response in Neuroendocrine Tumor Patients
Journal of the American College of Surgeons · 2019
Can we improve the specificity of Parathyroid SPECT/CT scans by better pre test selection ?
2019
CT texture analysis of pancreatic cancer
European Radiology · 2018
Functional liver image guided hepatic therapy (FLIGHT) with hepatobiliary iminodiacetic acid (HIDA) scans
Practical Radiation Oncology · 2018
High diagnostic accuracy of hybrid, contrast-enhanced tc99m sestamibi SPECT/4DCT for preoperative parathyroid adenoma localization
Journal of Nuclear Medicine · 2016

Publishes in

The Journal of Urology×12
Journal of Clinical Oncology×10
Journal of Nuclear Medicine×5
Gastroenterology×5
European Journal of Nuclear Medicine and Molecular Imaging×4

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile